Review article: Spontaneous bacterial peritonitis - Diagnosis, treatment and prevention

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 12, 2001, Pages 1851-1859

  Mowat, C ^a   Stanley, A J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; OFLOXACIN;

ANTIBIOTIC RESISTANCE; ASCITES; ASCITES FLUID; BACTERIAL PERITONITIS; DRUG COST; GASTROINTESTINAL HEMORRHAGE; GRAM NEGATIVE BACTERIUM; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

ALBUMINS; ANTI-BACTERIAL AGENTS; ASCITES; ASCITIC FLUID; BACTERIAL INFECTIONS; CLINICAL TRIALS; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PERITONITIS;

EID: 0035665870     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01116.x     Document Type: Review

References (70)

1. Spontaneous bacterial peritonitis
2. Hepatorenal syndrome and renal dysfunction associated with liver disease
3. Pathogenesis of ascites in cirrhosis
4. Survival and prognostic indicators in compensated and decompensated cirrhosis
5. Prognostic significance of renal dysfunction in cirrhosis
6. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
7. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis
8. Renal function abnormalities in cirrhosis
9. Infections in liver disease
10. Spontaneous bacterial peritonitis
11. A prospective study of bacterial infections in patients with cirrhosis
12. Spontaneous bacterial peritonitis: Outcome and predictive factors
13. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis
14. Reticulo-endothelial system phagocytic activity in cirrhosis and its relationship to bacterial infections and prognosis
15. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis
16. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis
17. Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors
18. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites
19. Ascites and spontaneous bacterial peritonitis in fulminant hepatic failure
20. Management of adult patients with ascites caused by cirrhosis
21. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document
22. Spontaneous bacterial peritonitis
23. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections
24. Bacterial translocation in acute and chronic portal hypertension
25. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites
26. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: Molecular epidemiologic evidence
27. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis
28. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis
29. Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime
30. The pathogenesis of sepsis
31. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock
32. Tumour necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality
33. Serial analysis of serum and ascitic fluid levels of soluble adhesion molecules and chemokines in patients with SBP
34. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis
35. Optimisation of ascitic fluid culture technique
36. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis
37. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis
38. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomised, multicentre study
39. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination
40. Short-course ceftriaxone therapy in spontaneous bacterial peritonitis
41. Amoxicillin-clavulinic acid therapy of spontaneous bacterial peritonitis: A prospective study of twenty-seven cases in cirrhotic patients
42. Amoxicillin-clavulinic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients
43. Randomized. Comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis
44. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: Results of a multicenter randomized study
45. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis
46. Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis
47. Albumin infusion for spontaneous bacterial peritonitis
48. Current management of the complications of cirrhosis and portal hypertension. Variceal hemorrhage, ascites and spontaneous bacterial peritonitis
49. Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation
50. Spontaneous bacterial peritonitis: An indication for liver transplantation?
51. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites
52. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis
53. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
54. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration
55. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin
56. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: A double-blind randomized trial
57. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic protein levels
58. A prospective evaluation of bacteraemic patients with chronic liver disease
59. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage
60. Prognostic significance of bacterial infection in bleeding cirrhotic patients: A prospective study
61. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal haemorrhage
62. Systemic antibiotic therapy prevents bacterial infections in cirrhotic patients with gastrointestinal haemorrhage
63. Antimicrobial prophylaxis after gastrointestinal haemorrhage for cirrhotic patients with a high risk of infection
64. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding
65. BSG guidelines on variceal bleeding
66. Efficacy of oral ciprofloxacin as selective intestinal decontamination in cirrhosis
67. Effects of oral ciprofloxacin on aerobic gram-negative faecal flora in patients with cirrhosis: Results of short and long-term administration with daily and weekly dosages
68. Cost analysis of prophylactic antibiotics in spontaneous bacterial peritonitis
69. An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis
70. Spontaneous bacterial peritonitis